Topical capsaicin in burning mouth syndrome

The efficacy of topical capsaicin in reducing symptoms in patients with burning mouth syndrome

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12608000235303

Acronym

BMS capsaicin

Enrollment

Registered

2008-05-08

Start date

2007-12-10

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Patients will be instructed to apply topical capsaicin 0.075%, twice a day (middle morning and middle afternoon) for 8 weeks with a one-week interval - the fourth.

Study design

Allocation

Non-randomised trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

burning mouth syndrome, no recent use of other drugs

Exclusion criteria

diabetic patients, anemia, candida infection

Outcome results